IWA
IONS icon

Icon Wealth Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Icon Wealth Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,391
Closed -$104K – 470
2024
Q1 		$104K Sell
2,391
-146
-6% -$6.96K 0.01% 457
2023
Q4 		$128K Buy
+2,537
New +$122K 0.01% 390
2022
Q4 		– Sell
-2,884
Closed -$128K – 375
2022
Q3 		$128K Buy
+2,884
New +$122K 0.02% 359

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Icon Wealth Advisors's IONS Position: Q2 2024 in Review

Icon Wealth Advisors sold out of Ionis Pharmaceuticals (IONS) in Q2 2024, closing a stake of 2,391 shares — an estimated $104K sold.

Icon Wealth Advisors first reported a position in IONS in Q3 2022 and held it in 3 quarters. The position peaked at $128K in Q4 2023. 356 funds tracked by Wall St. Rank hold IONS as of Q2 2024.

  • Icon Wealth Advisors reported no remaining Ionis Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Icon Wealth Advisors sold 2,391 Ionis Pharmaceuticals shares in Q2 2024, an estimated $104K.
  • Icon Wealth Advisors first reported a position in Ionis Pharmaceuticals in Q3 2022 and held it in 3 quarters.
  • Icon Wealth Advisors's Ionis Pharmaceuticals position peaked at $128K in Q4 2023.
  • 356 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2024.

Based on Icon Wealth Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.